Equities

Lionsgate Studios Corp

LION:NSQ

Lionsgate Studios Corp

Actions
Consumer DiscretionaryMedia
  • Price (USD)7.08
  • Today's Change0.03 / 0.43%
  • Shares traded100.46k
  • 1 Year change-33.14%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 19:06 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy1
Outperform2
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The 3 analysts offering 12 month price targets for Lionsgate Studios Corp have a median target of 10.00, with a high estimate of 13.00 and a low estimate of 8.00. The median estimate represents a 41.84% increase from the last price of 7.05.
High84.4%13.00
Med41.8%10.00
Low13.5%8.00

Earnings history & estimates in USD

On Nov 08, 2024, Lionsgate Studios Corp reported 2nd quarter 2025 losses of -0.31 per share.
More ▼

Revenue history & estimates in USD

Lionsgate Studios Corp had 2nd quarter 2025 revenues of 823.70m. This bettered the 804.00m consensus of the 2 analysts covering the company. The same period last year the company did not report revenues.
Average growth rate+39.99%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.